Aurinia Pharmaceuticals (AUPH) Times Interest Earned (2019 - 2025)
Historic Times Interest Earned for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Q3 2025 value amounting to $27.07.
- Aurinia Pharmaceuticals' Times Interest Earned rose 17830.39% to $27.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.81, marking a year-over-year increase of 34169.7%. This contributed to the annual value of -$0.97 for FY2024, which is 9706.62% up from last year.
- As of Q3 2025, Aurinia Pharmaceuticals' Times Interest Earned stood at $27.07, which was up 17830.39% from $17.98 recorded in Q2 2025.
- Over the past 5 years, Aurinia Pharmaceuticals' Times Interest Earned peaked at $160.32 during Q4 2021, and registered a low of -$248.77 during Q2 2023.
- For the 4-year period, Aurinia Pharmaceuticals' Times Interest Earned averaged around -$5.5, with its median value being -$1.26 (2024).
- As far as peak fluctuations go, Aurinia Pharmaceuticals' Times Interest Earned soared by 9357.07% in 2024, and later skyrocketed by 152361.75% in 2025.
- Aurinia Pharmaceuticals' Times Interest Earned (Quarter) stood at $160.32 in 2021, then tumbled by 114.13% to -$22.65 in 2023, then skyrocketed by 93.57% to -$1.46 in 2024, then skyrocketed by 1958.42% to $27.07 in 2025.
- Its Times Interest Earned stands at $27.07 for Q3 2025, versus $17.98 for Q2 2025 and $20.48 for Q1 2025.